| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 03/09/2011 | EP2188280B1 Imidazopyridinones |
| 03/09/2011 | EP1841735B1 Indoles useful in the treatment of inflammation |
| 03/09/2011 | EP1692116B1 1,2,3-triazole amide derivatives as inhibitors of cytokine production |
| 03/09/2011 | EP1620434B1 Fused bicyclic-substituted amines as histamine-3 receptor ligands |
| 03/09/2011 | EP1569910B1 Pesticidal sulphonylaminopyrazoles |
| 03/09/2011 | EP1497279B1 Substituted indoles and their use as 5ht-reuptake inhibitors and as 5ht ligands |
| 03/09/2011 | CN101580501B Synthetic method of 3-(substituted dihydro-isoindolone-2-group)-2,6-dioxopiperidine and intermediate thereof |
| 03/09/2011 | CN101326167B Pyridiazinone derivatives for tumour treatment |
| 03/08/2011 | US7902369 Diaryl-substituted five-membered heterocycle derivative |
| 03/08/2011 | US7902241 Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease |
| 03/08/2011 | US7902239 Diaminotriazoles useful as inhibitors of protein kinases |
| 03/08/2011 | US7902225 Mycobacterial inhibitors |
| 03/08/2011 | US7902223 Phenyl derivatives as factor XA inhibitors |
| 03/08/2011 | US7902217 Indoles, 1H-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof |
| 03/08/2011 | US7902187 6-substituted 2-(benzimidazolyl)purine and purinone derivatives for immunosuppression |
| 03/08/2011 | US7902181 Compounds 010 |
| 03/08/2011 | CA2488202C 1-aryl-4-substituted piperazine derivatives for use as ccr1 antagonists for the treatment of inflammation and immune disorders |
| 03/08/2011 | CA2468691C 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists |
| 03/08/2011 | CA2446756C Thiazole compounds useful as inhibitors of protein kinase |
| 03/08/2011 | CA2420899C Hydroxamate derivatives useful as deacetylase inhibitors |
| 03/08/2011 | CA2415396C 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications |
| 03/03/2011 | WO2011025541A1 Cannabinoid receptor modulators |
| 03/03/2011 | WO2011025006A1 Gpr119 agonist |
| 03/03/2011 | WO2011024986A1 Organic electroluminescence device |
| 03/03/2011 | WO2011024711A1 Novel compound amycolose derivative, and production process and use of same |
| 03/03/2011 | WO2011023989A1 Aromatase inhibitor |
| 03/03/2011 | WO2011022928A1 Quinolines compounds, their preparation methods, pharmaceutical compositions containing the same and use thereof |
| 03/03/2011 | WO2011006794A8 3-oxo-2, 3-dihydro-1h-isoindole-4-carboxamides as parp inhibitors |
| 03/03/2011 | WO2010128528A9 Piperidine derivatives useful for treatment of diebetes |
| 03/03/2011 | US20110054182 Novel Process for the Preparation of 4-Aminobut-2-enolides |
| 03/03/2011 | US20110054172 Pyridylaminoacetic acid compound |
| 03/03/2011 | US20110054165 Xanthene dyes |
| 03/03/2011 | US20110053997 Salts and Crystal Forms |
| 03/03/2011 | US20110053972 Inhibitors of akt activity |
| 03/03/2011 | US20110053964 4-aminoquinazoline derivatives and methods of use thereof |
| 03/03/2011 | US20110053941 IDO Inhibitors |
| 03/03/2011 | US20110053912 Pyrimidine compound |
| 03/03/2011 | US20110053891 5-fluoropyrimidinone derivatives |
| 03/03/2011 | US20110053878 Acid-sensitive linkers for drug delivery |
| 03/03/2011 | US20110052696 Dendrimers with interior and exterior functionalities comprising of azide or alkyne groups for post-functionalization by the huisgen click cycloaddition |
| 03/03/2011 | US20110052589 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors |
| 03/03/2011 | US20110052562 Benzimidazoles and analogs as rho kinase inhibitors |
| 03/03/2011 | US20110049445 Photochromic materials having extended pi-conjugated systems and compositions and articles including the same |
| 03/03/2011 | CA2770866A1 Cannabinoid receptor modulators |
| 03/03/2011 | CA2770480A1 Pyranyl aryl methyl benzoquinazolinone m1 receptor positive allosteric modulators |
| 03/03/2011 | CA2770475A1 Novel pyrrolidine derived beta 3 adrenergic receptor agonists |
| 03/02/2011 | EP2289888A2 Epoxycarboxylic acid amides, azides and amino alcohols and processes for preparation of alpha-keto amides by using them |
| 03/02/2011 | EP2289887A2 Epoxycarboxylic acid amides, azides and amino alcohols and processes for preparation of alpha-keto amides by using them |
| 03/02/2011 | EP2289564A2 Derivatives of aniline as precursors for F18-labeling |
| 03/02/2011 | EP2288603A1 Tetrazole compounds as orexin receptor antagonists |
| 03/02/2011 | EP2288601A1 Bicyclylaryl-aryl-amine compounds and their use |
| 03/02/2011 | EP2181098B1 2-(substituted phenyl)-6-amino-5-alkoxy, thioalkoxy and aminoalkyl-4-pyrimidinecarboxylates and their use as herbicides |
| 03/02/2011 | EP2069332B1 Azetidine compounds as orexin receptor antagonists |
| 03/02/2011 | EP1966146B1 4,5-dihydro- (1h)-pyrazole derivatives as cannabinoid cb1 receptor modulators |
| 03/02/2011 | EP1957479B1 1,5-substituted indol-2-yl amide derivatives |
| 03/02/2011 | EP1853592B1 Synthesis of himbacine analogs |
| 03/02/2011 | EP1831174B1 Amide derivatives |
| 03/02/2011 | EP1581518B1 Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists |
| 03/02/2011 | EP1578715B1 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 03/02/2011 | EP1383761B1 Phenyl- and pyridyl-piperidines with tnf activity |
| 03/02/2011 | EP1001945B1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56lck TYROSINE KINASES |
| 03/02/2011 | CN101983202A Luminescence quenchers and fluorogenic probes for detection of reactive species |
| 03/02/2011 | CN101983196A Substituted enaminothiocarbonyl compounds |
| 03/02/2011 | CN101983188A Indolinone compound |
| 03/02/2011 | CN101193869B Glucocortioid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 03/02/2011 | CN101104604B Optically pure dihydropyrimidine compounds and use for the same in preparing medicament for curing and preventing virosis |
| 03/01/2011 | US7897635 HIV protease inhibitors |
| 03/01/2011 | US7897634 Pyrazoles for the treatment of obesity and other CNS disorders |
| 03/01/2011 | US7897633 Neuronal disorders such as Alzheimer's disease, Down Syndrome, Parkinson disease, Chorea Huntington, pathogenic psychotic conditions, schizophrenia, impaired food intake, sleep-wakefulness, impaired homeostatic regulation of energy metabolism, impaired autonomic function; alcoholism |
| 03/01/2011 | US7897631 Inhibition and dispersion of bacterial biofilms with imidazole-triazole derivatives |
| 03/01/2011 | US7897627 Heteroaryl derivatives as orexin receptor antagonists |
| 03/01/2011 | US7897618 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 03/01/2011 | US7897594 Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof |
| 03/01/2011 | CA2602348C Cyclopentapyridine and tetrahydroquinoline derivatives |
| 03/01/2011 | CA2468529C 4-(2-furoyl) aminopiperidines, intermediates in synthesizing the same, process for producing the same and medicinal use of the same |
| 02/24/2011 | WO2011022348A1 Ethylene diamine modulators of fatty acid amide hydrolase |
| 02/24/2011 | WO2011021726A2 Nitrogen-containing compound and pharmaceutical composition |
| 02/24/2011 | WO2011021689A1 Cyclic azine derivatives, processes for producing these, and organic electroluminescent element containing these as component |
| 02/24/2011 | WO2011021224A2 Process for (5-methyl-2-oxo-1,3-dioxolen-4-yl)methyl4-(1-hydroxy-1-methylethyl)-2-propyl-1-[4-[2-tetrazol-5-yl)phenyl]phenyl]methylimidazole-5-carboxylate |
| 02/24/2011 | WO2011020886A1 Novel quinoline-hepcidine antagonists |
| 02/24/2011 | WO2011020288A1 Substituted hydrazide compounds and application thereof |
| 02/24/2011 | WO2010130752A3 High-molecular non-polar benztriazoles |
| 02/24/2011 | WO2010129211A3 Preparation of decitabine |
| 02/24/2011 | US20110046379 Quinoline Compounds, Intermediates, Preparation Methods and Uses Thereof |
| 02/24/2011 | US20110046378 Novel Imaging Agents for Detecting Neurological Dysfunction |
| 02/24/2011 | US20110046182 Efficient aspirin prodrugs |
| 02/24/2011 | US20110046168 Methods of treating diseases using quinazoline derivatives and pharmaceutical compositions containing them |
| 02/24/2011 | US20110046146 Phosphodiesterase 4 inhibitors |
| 02/24/2011 | US20110046139 Benzocycloheptane and benzoxepine derivatives |
| 02/24/2011 | US20110046113 Amine compound and use thereof |
| 02/24/2011 | US20110046110 Quinolines and related analogs as sirtuin modulators |
| 02/24/2011 | US20110046108 Pyrimidine derivatives |
| 02/24/2011 | CA2771579A1 Nitrogen-containing compound and pharmaceutical composition |
| 02/24/2011 | CA2771234A1 Substituted hydrazide compounds and use thereof |
| 02/23/2011 | EP2287156A1 2,4-Di(phenylamino)-pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 02/23/2011 | EP2287155A1 Acylthiourea compound or salt thereof, and use of the compound or the salt |
| 02/23/2011 | EP2286811A1 Chemokine receptor antagonists and methods of use thereof |
| 02/23/2011 | EP2285802A1 Oxo-imidazolyl compounds having antibacterial activity |
| 02/23/2011 | EP2285800A1 Quinoline or isoquinoline substituted p2x7 antagonists |
| 02/23/2011 | EP2285794A2 Chromane derivatives as trpv3 modulators |